Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives

With strong 1-year returns and upside potential, Ventyx Biosciences, Inc. (NASDAQ:VTYX) secures a spot on our list of the 12 best multibagger stocks to buy heading into 2026. Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives As of December 18, 2025, 90% of analysts are bullish on Ventyx Biosciences, Inc. (NASDAQ:VTYX), setting a median price target of $14.00. This translates into a massive upside potential of 82.05%. Amid this bullish momentum, Ventyx Bioscien ...